Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Top-selling biotech drugs based on revenue 2017

Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)

by Matej Mikulic, last edited Aug 8, 2019
Top-selling biotech drugs based on revenue 2017 This statistic shows a ranking of the top 10 best-selling biotech drugs worldwide in 2017. In that year, Enbrel generated a revenue of some 7.9 billion U.S. dollars for co-marketing companies Amgen, Pfizer, Takeda (Japan), and Wyeth (rest of world), and thus was the world's third biotech drug based on revenue.
Best-selling biotech drugs worldwide

AbbVie’s Humira and Roche's Rituxan are among the top selling biotechnology drugs in the world, generating 18.4 billion U.S. dollars and 9.2 billion U.S. dollars, respectively, in 2017. Biotechnology has become more prevalent within the pharmaceutical industry. One of the first uses of biotechnology was for human insulin. The United States had around 860 dedicated biotechnology companies in 2015. However, one of the largest biotechnology companies in the world is headquartered in Basel, Switzerland. Roche generated some 34 billion U.S. dollars in biotech prescription drug revenues in 2017 and is expected to reach 42 billion U.S. dollars in 2024. One of their top selling drugs, Avastin, generated about 7.1 billion U.S. dollars in revenue in 2017. Avastin is a drug derived from biotechnology that is used to inhibit the growth of new blood vessels to treat some types of cancer.

The United States spent about 28.6 billion U.S. dollars on research and development in the biotechnology sector. The United States has also had about 34 percent of the world’s share of filed biotechnology patents in 2014, in comparison, Germany filed eight percent of global biotech patents.
Show more

Top selling biotech drugs worldwide in 2017 (in billion U.S. dollars)

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
Pharmaceutical brands: Humira (AbbVie)
Pharmaceutical brands: Humira (AbbVie)

All Information
in one Presentation

Pharmaceutical brands: Humira (AbbVie)

Everything On "Pharmaceutical brands: Humira (AbbVie)" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.

Other Reports & Dossiers
Statista has been my savior on several occasions. The site is easy to maneuver and the data is in a format that can go right into a report or presentation.
Marlene Greenfield

Marlene Greenfield
Vice President, Hearst Magazines

Statistics on "Biotech industry"
  • Global overview
  • U.S. companies
  • Research & development
  • Products
  • Funding/investment
  • Biotech in agriculture
Discover Statista
Need help with using Statista for your research? Tutorials and first steps
Further Content: You might find this interesting as well
Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.
Do you have any questions about our business solutions?

We provide you with detailed information about our Corporate Account.